Viveve Medical, Inc. (VIVE) DCF Valuation
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Viveve Medical, Inc. (VIVE) Bundle
Take charge of your Viveve Medical, Inc. (VIVE) valuation analysis with our state-of-the-art DCF Calculator! Packed with real (VIVE) data, this Excel template enables you to adjust forecasts and assumptions for an accurate calculation of Viveve Medical's intrinsic value.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2017 |
AY2 2018 |
AY3 2019 |
AY4 2020 |
AY5 2021 |
FY1 2022 |
FY2 2023 |
FY3 2024 |
FY4 2025 |
FY5 2026 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 15.3 | 18.5 | 6.6 | 5.5 | 6.4 | 5.7 | 5.1 | 4.6 | 4.1 | 3.7 |
Revenue Growth, % | 0 | 21.12 | -64.54 | -16.57 | 17.28 | -10.67 | -10.67 | -10.67 | -10.67 | -10.67 |
EBITDA | -33.3 | -44.2 | -30.7 | -18.5 | -19.6 | -5.7 | -5.1 | -4.6 | -4.1 | -3.7 |
EBITDA, % | -218.09 | -238.52 | -467.17 | -337.56 | -305.51 | -100 | -100 | -100 | -100 | -100 |
Depreciation | .4 | .8 | 1.2 | 1.3 | 1.1 | .8 | .7 | .6 | .5 | .5 |
Depreciation, % | 2.94 | 4.24 | 18 | 23.67 | 17.72 | 13.32 | 13.32 | 13.32 | 13.32 | 13.32 |
EBIT | -33.8 | -45.0 | -31.9 | -19.8 | -20.8 | -5.7 | -5.1 | -4.6 | -4.1 | -3.7 |
EBIT, % | -221.02 | -242.76 | -485.17 | -361.23 | -323.23 | -100 | -100 | -100 | -100 | -100 |
Total Cash | 20.7 | 29.5 | 13.3 | 6.5 | 19.2 | 5.7 | 5.1 | 4.6 | 4.1 | 3.7 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | 6.2 | 5.7 | 1.6 | .8 | .5 | 1.4 | 1.2 | 1.1 | 1.0 | .9 |
Account Receivables, % | 40.64 | 30.8 | 23.95 | 14.05 | 8.54 | 23.6 | 23.6 | 23.6 | 23.6 | 23.6 |
Inventories | 2.4 | 4.1 | 4.9 | 3.3 | 1.5 | 2.2 | 2.0 | 1.8 | 1.6 | 1.4 |
Inventories, % | 15.63 | 22.24 | 74.02 | 59.39 | 22.91 | 38.84 | 38.84 | 38.84 | 38.84 | 38.84 |
Accounts Payable | 4.8 | 4.0 | 1.6 | .9 | 1.5 | 1.3 | 1.2 | 1.1 | 1.0 | .9 |
Accounts Payable, % | 31.39 | 21.57 | 24.49 | 16.08 | 23.03 | 23.31 | 23.31 | 23.31 | 23.31 | 23.31 |
Capital Expenditure | -.9 | -2.1 | -1.1 | -.8 | -.5 | -.6 | -.6 | -.5 | -.5 | -.4 |
Capital Expenditure, % | -5.92 | -11.57 | -16.55 | -14.25 | -7.1 | -11.08 | -11.08 | -11.08 | -11.08 | -11.08 |
Tax Rate, % | -1.18 | -1.18 | -1.18 | -1.18 | -1.18 | -1.18 | -1.18 | -1.18 | -1.18 | -1.18 |
EBITAT | -33.5 | -44.8 | -35.5 | -19.5 | -21.0 | -5.7 | -5.1 | -4.6 | -4.1 | -3.6 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -37.7 | -48.2 | -34.4 | -17.3 | -17.7 | -7.3 | -4.7 | -4.2 | -3.8 | -3.4 |
WACC, % | 18.52 | 18.64 | 18.69 | 18.44 | 18.69 | 18.6 | 18.6 | 18.6 | 18.6 | 18.6 |
PV UFCF | ||||||||||
SUM PV UFCF | -15.4 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | -3 | |||||||||
Terminal Value | -21 | |||||||||
Present Terminal Value | -9 | |||||||||
Enterprise Value | -24 | |||||||||
Net Debt | -14 | |||||||||
Equity Value | -10 | |||||||||
Diluted Shares Outstanding, MM | 10 | |||||||||
Equity Value Per Share | -1.04 |
What You Will Get
- Editable Forecast Inputs: Easily modify assumptions (growth %, margins, WACC) to explore various scenarios.
- Real-World Data: Viveve Medical’s financial data pre-loaded to facilitate your analysis.
- Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
- Customizable and Professional: A refined Excel model that adjusts to your valuation requirements.
- Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.
Key Features
- Genuine Viveve Financials: Gain access to precise pre-loaded historical data and future forecasts.
- Adjustable Forecast Parameters: Modify highlighted cells for metrics such as WACC, growth rates, and profit margins.
- Real-Time Calculations: Automatic updates for DCF, Net Present Value (NPV), and cash flow assessments.
- Interactive Dashboard: User-friendly charts and summaries to help visualize your valuation outcomes.
- Suitable for All Skill Levels: An intuitive layout designed for investors, CFOs, and consultants alike.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review Viveve Medical's pre-filled financial data and forecasts.
- Step 3: Modify key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model update in real-time as you adjust assumptions.
- Step 5: Analyze the outputs and leverage the results for your investment strategies.
Why Choose This Calculator for Viveve Medical, Inc. (VIVE)?
- Designed for Experts: A sophisticated tool utilized by healthcare analysts, investors, and medical consultants.
- Accurate Data: Viveve Medical’s historical and projected financials preloaded for precise analysis.
- Flexible Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
- Comprehensive Outputs: Automatically calculates intrinsic value, NPV, and essential metrics.
- User-Friendly Interface: Step-by-step guidance makes the process straightforward.
Who Should Use This Product?
- Investors: Evaluate Viveve Medical’s valuation before making investment decisions.
- CFOs and Financial Analysts: Enhance valuation methodologies and assess financial forecasts.
- Startup Founders: Understand the valuation practices of established medical technology companies like Viveve.
- Consultants: Provide detailed valuation analysis and reports for healthcare clients.
- Students and Educators: Utilize real-world case studies to learn and teach valuation principles.
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled Viveve Medical historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios for Viveve Medical, Inc. (VIVE).
- Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.